Merit Medical Systems Total Assets 2012-2025 | MMSI

Merit Medical Systems total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Merit Medical Systems Annual Total Assets
(Millions of US $)
2024 $2,419
2023 $2,325
2022 $1,664
2021 $1,648
2020 $1,664
2019 $1,757
2018 $1,620
2017 $1,112
2016 $943
2015 $779
2014 $747
2013 $728
2012 $705
2011 $447
Merit Medical Systems Quarterly Total Assets
(Millions of US $)
2025-09-30 $2,631
2025-06-30 $2,586
2025-03-31 $2,468
2024-12-31 $2,419
2024-09-30 $2,378
2024-06-30 $2,372
2024-03-31 $2,326
2023-12-31 $2,325
2023-09-30 $1,809
2023-06-30 $1,838
2023-03-31 $1,684
2022-12-31 $1,664
2022-09-30 $1,633
2022-06-30 $1,632
2022-03-31 $1,630
2021-12-31 $1,648
2021-09-30 $1,643
2021-06-30 $1,642
2021-03-31 $1,652
2020-12-31 $1,664
2020-09-30 $1,671
2020-06-30 $1,716
2020-03-31 $1,749
2019-12-31 $1,757
2019-09-30 $1,762
2019-06-30 $1,736
2019-03-31 $1,690
2018-12-31 $1,620
2018-09-30 $1,310
2018-06-30 $1,291
2018-03-31 $1,239
2017-12-31 $1,112
2017-09-30 $1,087
2017-06-30 $1,052
2017-03-31 $1,015
2016-12-31 $943
2016-09-30 $929
2016-06-30 $815
2016-03-31 $803
2015-12-31 $779
2015-09-30 $768
2015-06-30 $755
2015-03-31 $740
2014-12-31 $747
2014-09-30 $747
2014-06-30 $744
2014-03-31 $742
2013-12-31 $728
2013-09-30 $718
2013-06-30 $728
2013-03-31 $712
2012-12-31 $705
2012-09-30 $519
2012-06-30 $500
2012-03-31 $489
2011-12-31 $447
2011-09-30 $419
2011-06-30 $458
2011-03-31 $380
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.948B $1.357B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $101.611B 22.70
Becton Dickinson (BDX) United States $58.742B 14.30
Cardinal Health (CAH) United States $49.531B 23.40
Straumann Holding AG (SAUHY) Switzerland $19.438B 0.00
West Pharmaceutical Services (WST) United States $18.357B 36.09
Cooper (COO) United States $16.176B 19.99
Align Technology (ALGN) United States $12.194B 23.03
Henry Schein (HSIC) United States $9.293B 16.38
DENTSPLY SIRONA (XRAY) United States $2.541B 8.06
CONMED (CNMD) United States $1.287B 9.19
STAAR Surgical (STAA) United States $1.025B 0.00
Pro-Dex (PDEX) United States $0.133B 15.90
Lifevantage (LFVN) United States $0.072B 6.87
Axe Compute (AGPU) United States $0.021B 0.00